We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
-1.23%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$300M
AUM Growth
+$12.2M
Cap. Flow
+$19.5M
Cap. Flow %
6.5%
Top 10 Hldgs %
38.79%
Holding
113
New
9
Increased
9
Reduced
35
Closed
13

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$8.11M
2
AMGN icon
Amgen
AMGN
+$6.68M
3
CI icon
Cigna
CI
+$6.42M
4
META icon
Meta Platforms (Facebook)
META
+$5.43M
5
FLEX icon
Flex
FLEX
+$5.28M

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$1.81M
2
BIB icon
ProShares Ultra NASDAQ Biotechnology
BIB
+$1.76M
3
BX icon
Blackstone
BX
+$1.39M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.26M
5
IMBI
iMedia Brands, Inc. Class A Common Stock
IMBI
+$1.11M

Sector Composition

Rank Sector Weight
1 Healthcare 27.15%
2 Communication Services 17.59%
3 Technology 15.86%
4 Industrials 9.86%
5 Miscellaneous 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$29.8M 9.94%
385,549
– –
AAPL icon
2
Apple
AAPL
$4.67T
$12.5M 4.17%
298,252
+720
+0.2% +$31K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.24T
$11.5M 3.83%
221,660
+32,580
+17% +$1.81M
META icon
4
Meta Platforms (Facebook)
META
$1.47T
$11.5M 3.82%
71,703
+30,257
+73% +$5.43M
IBB icon
5
iShares Biotechnology ETF
IBB
$10.5B
$9.89M 3.29%
92,617
+73,184
+377% +$8.11M
BX icon
6
Blackstone
BX
$107B
$9.14M 3.04%
286,087
-40,639
-12% -$1.39M
RTN
7
DELISTED
Raytheon Company
RTN
$8.53M 2.84%
39,503
-555
-1% -$115K
INTC icon
8
Intel
INTC
$473B
$8.14M 2.71%
156,241
+612
+0.4% +$29.1K
TMO icon
9
Thermo Fisher Scientific
TMO
$230B
$7.9M 2.63%
38,284
-235
-0.6% -$49.3K
V icon
10
Visa
V
$712B
$7.57M 2.52%
63,275
-1,580
-2% -$191K
PARA
11
DELISTED
Paramount Global Class B
PARA
$7.27M 2.42%
141,530
-3,050
-2% -$168K
UNH icon
12
UnitedHealth
UNH
$353B
$7.21M 2.4%
33,707
-425
-1% -$97.1K
CSCO icon
13
Cisco
CSCO
$433B
$6.74M 2.24%
157,050
-1,150
-0.7% -$48.8K
ADBE icon
14
Adobe
ADBE
$116B
$6.71M 2.23%
31,039
-325
-1% -$66.1K
CMCSA icon
15
Comcast
CMCSA
$96B
$6.7M 2.23%
196,044
-3,260
-2% -$126K
AMGN icon
16
Amgen
AMGN
$234B
$6.2M 2.07%
+36,375
New +$6.68M
EPD icon
17
Enterprise Products Partners
EPD
$84.3B
$6.13M 2.04%
250,322
-2,570
-1% -$68.4K
UNP icon
18
Union Pacific
UNP
$183B
$5.9M 1.97%
43,920
-1,475
-3% -$198K
T icon
19
AT&T
T
$178B
$5.89M 1.96%
218,745
-12,208
-5% -$340K
CI icon
20
Cigna
CI
$73.7B
$5.54M 1.84%
+33,010
New +$6.42M
PFE icon
21
Pfizer
PFE
$159B
$5.33M 1.78%
158,380
-3,162
-2% -$109K
MPLX icon
22
MPLX
MPLX
$60.1B
$5.25M 1.75%
158,755
-1,933
-1% -$69.3K
LMT icon
23
Lockheed Martin
LMT
$130B
$5.16M 1.72%
15,269
-125
-0.8% -$42.5K
LYB icon
24
LyondellBasell Industries
LYB
$20.6B
$5.16M 1.72%
48,795
-250
-0.5% -$27.9K
BXMT icon
25
Blackstone Mortgage Trust
BXMT
$2.31B
$5.04M 1.68%
160,488
+945
+0.6% +$29.6K
1
2 3 4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Private Capital Advisors held 113 positions worth $300M, up 4.2% from $288M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Private Capital Advisors deployed $19.5M of net new capital in Q1 2018, opening 9 new positions and adding to 9 existing holdings. Its largest new stake was Amgen: 36,375 shares worth $6.2M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was ProShares Ultra NASDAQ Biotechnology, an estimated $1.76M trimmed.

  • Private Capital Advisors's largest Q1 2018 buy was Amgen: 36,375 shares worth $6.2M.
  • Private Capital Advisors added most to iShares Biotechnology ETF in Q1 2018, an estimated $8.11M increase.
  • Private Capital Advisors's biggest Q1 2018 reduction was ProShares Ultra NASDAQ Biotechnology, cutting an estimated $1.76M.
  • Private Capital Advisors fully exited Halliburton in Q1 2018, selling an estimated $1.81M.
  • Private Capital Advisors's ten largest holdings make up 39% of its $300M portfolio in Q1 2018.
  • Private Capital Advisors opened 9 new positions and closed 13 in Q1 2018.
  • Private Capital Advisors's portfolio value rose 4.2% quarter-over-quarter to $300M.

Based on Private Capital Advisors's 13F filing for Q1 2018, filed 18 Apr 2018.